Sugi Predict

Sugi Predict / Compounds / SCHEMBL286929

SCHEMBL286929

SCHEMBL286929

O=C(O)c1ccc2sccc2n1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.48
▸ KDM4E B2RXH2 5/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ ACMSD Q8TDX5 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ CSNK2A2 P19784 6/20 0.41
▸ CSNK2B P67870 6/20 0.41
▸ CSNK2A1 P68400 6/20 0.41
▸ ECE1 P42892 1/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ GPR35 Q9HC97 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ DAO P14920 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230724 0.83 MAP3K14 (0.42) CSNK2A2CSNK2BCSNK2A1KMT2AMEN1
SCHEMBL30577686 0.83 MAP3K14 (0.42) CSNK2A2CSNK2BCSNK2A1KMT2AMEN1
SCHEMBL7534470 0.79 ALDH1A1 (0.44) KDM4EKMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL1219716 0.77 KDM4C (0.58) KDM4ETDP1KMT2AMEN1LMNA
SCHEMBL2175934 0.74 MGAM (0.64) MGAMKDM4EALOX15TSHRACMSD
SCHEMBL14911830 0.73 HSD17B10 (0.42) KDM4EKMT2AMEN1LMNAALDH1A1
SCHEMBL5174321 0.71 DYRK1A (0.32) KDM4EL3MBTL1
SCHEMBL842813 0.71 MGAM (0.46) MGAMKDM4EALOX15TSHRACMSD
SCHEMBL359924 0.70 GPR35 (0.37) MGAMKDM4EALOX15TDP1CSNK2A2
Lithium SCHEMBL31115468 0.69 MGAM (0.44) MGAMKDM4EALOX15TSHRACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102421760-A Dihydropyrimidinones useful as BACE2 inhibitors HOFFMANN LA ROCHE 2012-04-18 — — CN claimed
US-20100286158-A1 DIHYDROPYRIMIDINONES HOFFMANN-LA ROCHE, INC. 2010-11-11 — — US claimed
US-20180222905-A1 NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A AbbVie Deutschland GmbH & Co. KG (DE) 2018-08-09 — — US disclosed
US-20180222905-A1 NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A AbbVie Deutschland GmbH & Co. KG (DE) 2018-08-09 — — US disclosed
US-9938269-B2 Inhibitor compounds of phosphodiesterase type 10A ABBVIE INC. (US) 2018-04-10 — — US disclosed
US-9822124-B2 Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors INCYTE CORPORATION (US) 2017-11-21 — — US disclosed
US-9822124-B2 Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors INCYTE CORPORATION (US) 2017-11-21 — — US disclosed
US-9822124-B2 Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitors INCYTE CORPORATION (US) 2017-11-21 — — US disclosed
US-9657034-B2 Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors AbbVie Deuschland GmbH & Co. KG (DE) 2017-05-23 — — US disclosed
US-9657034-B2 Substituted furo[3,2-c]pyridines, thieno[3,2-c]pyridines, thieno[2,3-d]pyridazines and pyrido[3,4-d]pyridazines as phosphodiesterase type 10A inhibitors AbbVie Deuschland GmbH & Co. KG (DE) 2017-05-23 — — US disclosed
EP-2776418-B1 INHIBITORS OF PHOSPHODIESTERASE TYPE 10A ABBVIE DEUTSCHLAND (DE) 2017-01-04 — — EP disclosed
EP-0781774-A2 Prolactin production inhibitory agents TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-07-02 — — EP disclosed
EP-0691972-A1 FURO 3,2-b]PYRIDINES AND THIENO 3,2-b]PYRIDINES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS MERCK FROSST CANADA INC. (CA) 1996-01-17 — — EP disclosed
US-5472964-A Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists MERCK FROSST CANADA, INC. (CA) 1995-12-05 — — US disclosed
US-5374635-A Antiinflammatory agents, lipoxygenase inhibitor, antiallergens , cytoprotective agents MERCK FROSST CANADA, INC. (CA) 1994-12-20 — — US disclosed
CN-1094051-A Leukotrienes antagonist-diaryl 5, the acid of 6-fused heterocycle MERCK FROSST CANADA INC (CA) 1994-10-26 — — CN disclosed
WO-1994022869-A1 FURO[3,2-b]PYRIDINES AND THIENO[3,2-b]PYRIDINES AS INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS MERCK FROSST CANADA INC. (CA) 1994-10-13 — — WO disclosed
WO-1994014815-A1 DIARYL 5,6-FUSEDHETEROCYCLIC ACIDS AS LEUKOTRIENE ANTAGONISTS MERCK FROSST CANADA INC. (CA) 1994-07-07 — — WO disclosed
EP-0604114-A1 Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1994-06-29 — — EP disclosed
US-4650514-A PRE- AND POSTEMERGENCE AMERICAN CYANAMID COMPANY (US) 1987-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180222905-A1 NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A PDE2A, PDE4A, PDE5A MGAM 3227/4885KDM4E 655/4885ALOX15 2869/4885
US-20100286158-A1 DIHYDROPYRIMIDINONES BACE2, BACE1, PSEN2 MGAM 1262/4885KDM4E 2548/4885ALOX15 4435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.